WPP:LSEWPP Plc Analysis
Data as of 2026-05-21 - not real-time
£275.40
Latest Price
8/10Risk
Risk Level: High
Executive Summary
WPP plc is trading at £275.4, comfortably above its 20‑day (£267.6) and 50‑day (£253.9) moving averages but still below the 200‑day average (£310.5), indicating a short‑term bullish tilt within a longer‑term neutral backdrop. The RSI sits at 58, well under overbought levels, while the MACD line (4.22) sits above its signal (3.83), reinforcing the modest upside momentum. However, the company reported an 8‑9% revenue decline in Q1 2026 and posted a negative profit margin (‑1.6%), with operating cash flow of £724m offset by a negative free cash flow of £‑63m, highlighting ongoing earnings pressure. The balance sheet is strained: debt‑to‑equity exceeds 240%, total debt (£6.8bn) dwarfs cash (£2.7bn), and ROE is negative, raising concerns about financial resilience. The dividend yield appears attractive at 5.45%, but a payout ratio above 110% suggests the payout is unsustainable and could be cut. Valuation metrics are mixed – a forward P/E of 5.1 is far below the industry average of 17.1, yet the DCF‑derived fair value (£219) lies well under the current price, implying the stock is overvalued on a fundamentals basis.
The technical picture is further clouded by decreasing volume, high 30‑day volatility (35%), and a beta of 0.71, indicating modest market sensitivity but elevated price swings. Market sentiment is extremely bullish (Fear & Greed Index 89.9), but recent aggressive sell‑offs in 2025 and the company's ongoing restructuring efforts add uncertainty. Given the combination of weak earnings, high leverage, and an over‑generous dividend, the upside potential appears limited despite the short‑term technical bias.
The technical picture is further clouded by decreasing volume, high 30‑day volatility (35%), and a beta of 0.71, indicating modest market sensitivity but elevated price swings. Market sentiment is extremely bullish (Fear & Greed Index 89.9), but recent aggressive sell‑offs in 2025 and the company's ongoing restructuring efforts add uncertainty. Given the combination of weak earnings, high leverage, and an over‑generous dividend, the upside potential appears limited despite the short‑term technical bias.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD and price above short‑term SMAs
- Decreasing volume and high volatility
- Unsustainable dividend payout
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Revenue decline and negative earnings trend
- High debt load limiting strategic flexibility
- Forward P/E suggests value but DCF indicates overvaluation
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent negative free cash flow and weak ROE
- Debt‑to‑equity ratio over 240% increasing financial risk
- Current price above DCF fair value with limited upside
Key Metrics & Analysis
Financial Health
Revenue Growth-8.30%
Profit Margin-1.59%
P/E Ratio5.1
ROE-5.29%
ROA0.94%
Debt/Equity246.47
P/B Ratio1.2
Op. Cash Flow£724.0M
Free Cash Flow£-63250000
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI58.1
Support£252.30
Resistance£286.90
MA 20£267.58
MA 50£253.89
MA 200£310.50
MACDBullish
VolumeDecreasing
Fear & Greed Index89.89
Valuation
Fair Value£219.39
Target Price£297.31
Upside/Downside7.95%
GradeOvervalued
TypeValue
Dividend Yield5.45%
Risk Assessment
Beta0.71
Volatility35.07%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.